About
Thesian Bio is a French biotechnology company developing in vivo CAR-T and CAR-M cell therapies using a lentiviral vector platform to treat cancer and autoimmune disorders by targeting immune cells directly within patients.
Explore Thesian Bio's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.